Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

estimate the utilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery in Sohag

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Incidence and Risk Factors of Surgical Site Infections After Coronary Artery Bypass Grafting Surgery

NCT07130422

CABG

COMPLETED

Risk Factors for Deep Sternal Wound Infection After Coronary Artery Bypass Grafting

NCT07043296

Coronary Artery Bypass Grafting

NOT_YET_RECRUITING

Continuous Comprehensive Nursing for Post-CABG Recovery

NCT07062432

Coronary Heart Disease (CHD)

COMPLETED NA

Effects of Triclosan-coated Sutures in Cardiac Surgery

NCT01212315

Postoperative Wound Infection

COMPLETED PHASE4

On-pump Versus Off-pump Coronary Artery Bypass Grafting , Short Term Outcomes , Sohag Experience

NCT06069986

Coronary Artery Disease

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection Due to Coronary Artery Bypass Graft (Diagnosis)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 1

* Preoperative:

1. Nightly CHG baths
2. Mupirocin nasal ointment twice daily for 2 to 5 days prior to surgery
3. Hair removal with clippers
* Intraoperative:

1. Skin antisepsis with CHG solution
2. Standardized IV antibiotic doses at the following time points :within 5 to 60 minutes of the initial surgical incision, with initiation of cardiopulmonary bypass ,and every 3 hours intraoperatively for the duration of the case.
* Postoperative :

1. The occlusive sternal dressing applied at time of chest closure and removed 48 hours postoperatively then daily dressing thereafter.
2. Daily postoperative linen change and minimize sternotomy exposure to home blankets

Group Type ACTIVE_COMPARATOR

Surgical wound infection prevention bundle

Intervention Type OTHER

utilization of locally customized surgical wound infection bundle to prevent and or control of infection in patients undergoing CABG surgery

group 2

* Preoperative:

1. Preoperative water and soap bath
2. Hair removal with razor
* Intraoperative:

1. Skin antisepsis with betadine solution
2. One dose of antibiotic just before skin incision
* Postoperative:

1. The occlusive sternal dressing removed 72 hours postoperatively then daily dressing
2. No specific concerns about linens change and home blankets exposure

Group Type NO_INTERVENTION

No interventions assigned to this group